41 related articles for article (PubMed ID: 35862035)
21. Comparative efficacy of immune checkpoint inhibitors combined with chemotherapy in patients with advanced driver-gene negative non-small cell lung cancer: A systematic review and network meta-analysis.
Zhang X; Wu M; Chen J; Zheng K; Du H; Li B; Gu Y; Jiang J
Heliyon; 2024 May; 10(10):e30809. PubMed ID: 38774326
[TBL] [Abstract][Full Text] [Related]
22. Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy.
Wang X; Wang L; Lin H; Zhu Y; Huang D; Lai M; Xi X; Huang J; Zhang W; Zhong T
Front Oncol; 2024; 14():1303335. PubMed ID: 38333685
[TBL] [Abstract][Full Text] [Related]
23. Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment.
Russo A; Lee JK; Pasquina LW; Del Re M; Dilks HH; Murugesan K; Madison RW; Lee Y; Schrock AB; Comment L; Dietrich M; Oxnard GR; Rolfo C
JCO Precis Oncol; 2024 Jan; 8():e2300535. PubMed ID: 38295321
[TBL] [Abstract][Full Text] [Related]
24. Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications.
Bertoli E; De Carlo E; Basile D; Zara D; Stanzione B; Schiappacassi M; Del Conte A; Spina M; Bearz A
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445976
[TBL] [Abstract][Full Text] [Related]
25. Clinical application of liquid biopsy based on circulating tumor DNA in non-small cell lung cancer.
Xin L; Yue Y; Zihan R; Youbin C; Tianyu L; Rui W
Front Physiol; 2023; 14():1200124. PubMed ID: 37351260
[TBL] [Abstract][Full Text] [Related]
26. [Initial Treatment of Aumolertinib in Combination with Bevacizumab for Advanced NSCLC with Primary EGFR T790M Mutation: A Report of Three Cases and Literature Review].
Yang X; Meng F; Zhong D
Zhongguo Fei Ai Za Zhi; 2023 Feb; 26(2):158-164. PubMed ID: 36872054
[TBL] [Abstract][Full Text] [Related]
27. AIMedGraph: a comprehensive multi-relational knowledge graph for precision medicine.
Quan X; Cai W; Xi C; Wang C; Yan L
Database (Oxford); 2023 Feb; 2023():. PubMed ID: 36856726
[TBL] [Abstract][Full Text] [Related]
28. Can Liquid Biopsy Based on ctDNA/cfDNA Replace Tissue Biopsy for the Precision Treatment of EGFR-Mutated NSCLC?
Li YZ; Kong SN; Liu YP; Yang Y; Zhang HM
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835972
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Clinical Outcomes of Icotinib in Patients With Clinically Diagnosed Advanced Lung Cancer With EGFR-Sensitizing Variants Assessed by Circulating Tumor DNA Testing: A Phase 2 Nonrandomized Clinical Trial.
Xu J; Liu Z; Bai H; Dong G; Zhong J; Wan R; Zang A; Li X; Li Q; Guo J; Du N; Zhong D; Huang Y; Lv Q; Zhang J; Zhao Y; Gao L; Li L; Zhang C; Zhao J; Li B; Liu Z; Yang Z; Ji D; Wang T; Duan J; Wang Z; Wang J
JAMA Oncol; 2022 Sep; 8(9):1328-1332. PubMed ID: 35862035
[TBL] [Abstract][Full Text] [Related]
30. Real-world efficacy and potential mechanism of resistance of icotinib in Asian advanced non-small cell lung cancer with EGFR uncommon mutations: A multi-center study.
Lei L; Wang WX; Zhu YC; Li JL; Fang Y; Wang H; Zhuang W; Zhang YB; Wang LP; Fang MY; Xu CW; Wang XJ; Lv TF; Song Y
Cancer Med; 2020 Jan; 9(1):12-18. PubMed ID: 31692291
[TBL] [Abstract][Full Text] [Related]
31. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Greenhalgh J; Boland A; Bates V; Vecchio F; Dundar Y; Chaplin M; Green JA
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD010383. PubMed ID: 33734432
[TBL] [Abstract][Full Text] [Related]
32. [Clinical Value of Droplet Digital PCR and Super-ARMS Detection of Epidermal Growth Factor Receptor Gene Mutation in Plasma Circulating Tumor DNA of Patients with Advanced Lung Adenocarcinoma].
Cao Z; Wang J; Qin N; Li K; Lv J; Wang J; Yang X; Li X; Zhang H; Zhang Q; Long H; Shu C; Ma L; Zhang S
Zhongguo Fei Ai Za Zhi; 2020 Feb; 23(2):84-90. PubMed ID: 32093452
[TBL] [Abstract][Full Text] [Related]
33. [Efficacy of icotinib for advanced non-small cell lung cancer patients with EGFR status identified].
Song Z; Yu X; Cai J; Shao L; Lin B; He C; Zhang B; Zhang Y
Zhongguo Fei Ai Za Zhi; 2013 Mar; 16(3):138-43. PubMed ID: 23514942
[TBL] [Abstract][Full Text] [Related]
34. Potential mechanism of primary resistance to icotinib in patients with advanced non-small cell lung cancer harboring uncommon mutant epidermal growth factor receptor: A multi-center study.
Lei L; Wang WX; Zhu YC; Li JL; Fang Y; Wang H; Zhuang W; Zhang YB; Wang LP; Fang MY; Xu CW; Wang XJ; Lv TF; Song Y
Cancer Sci; 2020 Feb; 111(2):679-686. PubMed ID: 31828849
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
